Amylyx Pharmaceuticals Inc (AMLX)

Investing Cash Flow

-$78.83M

TTM · Period ending: · USD

AMLX logo

AMLX Investing Cash Flow

Latest reported-$78.83M
AMLX TTM Cash from Investing (-$49.37M → -$78.83M)
High-resolution chart · PNG

AMLX investing cash flow history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Amylyx Pharmaceuticals Inc Investing Cash Flow — Trailing twelve months (TTM) (USD)
Period endingInvesting Cash Flow (USD)
-78,831,000
93,960,000
14,039,000
49,551,000
83,131,000
31,176,000
75,654,000
31,599,000
-115,305,000
36,878,000
92,053,000
-157,052,000
35,077,000
-83,683,000
-238,988,000
-7,994,000
-141,241,000
-145,703,000
-46,406,000
-49,371,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.